Chapter 16 -- Global Cytomegalovirus Treatment Market Analysis 2013-2017 and Opportunity Assessment 2018-2028 by Drug Type Based on drug type market analysis, the Cytomegalovirus treatment market is segmented into Ganciclovir, valganciclovir, Foscarnet
, Cidofovir and other.
Valacyclovir, famciclovir, brivudin, and foscarnet
can be used depending on the patient's clinical and metabolic status (3).
The in vitro susceptibility of EHV-1 to antiviral drugs Acyclovir (ACV), Ganciclovir (GCV), Foscarnet
(PFA), Famciclovir (FAM), Vidarabine (VID) and Cidofovir (CDV) was evaluated by plaque reduction assay (PRA).
Antitoxoplasmosis agent Sulfadiazine, Antiviral agent's acyclovir, indinavir, and foscarnet
used in the treatment of OIs caused by HIV, are all reported to cause intrarenal crystal deposition can cause AKI.
Reported treatments used foscarnet
as an alternative treatment to acyclovir.
, cidofovir, and leflunomide are second-line drugs used for Ganciclovir-resistant CMV infections .
Other causes of hypocalcemia in HIV infected patients are attributed to hypoalbuminemia , medications like foscarnet
 and Fanconi's syndrome related to antiretroviral medications .
IV ganciclovir, IV foscarnet
, IV cidofovir and oral valganciclovir are choices of antiviral available for CMV retinitis in both adults and children.
Due to these clinical and imagiological changes and because we could not exclude tuberculosis infection, classic first-line tuberculostatic therapy was empirically started (stopped after excluding this infection) and foscarnet
was added to ganciclovir (until a negative CMV viral load was achieved).
Intravitreal ganciclovir has been the mainstay of treatment for CMV retinits in South Africa (SA) and has been shown to have a better pharmacokinetic profile than intravitreal foscarnet
,  although recent evidence  suggests that systemic treatment should be considered.
 Recent developments have led to rapid laboratory detection techniques for systemic CMV and treatment regimens for CMV infection have been improved and are more readily available'[91 Current treatment regimens include intravenous ganciclovir (6 mg/kg, 12 hourly) as the drug of choice, and oral valganciclovir and intravenous foscarnet